NGL FINECHEM
Back to Income Statement
|
NGL FINECHEM Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹41 Cr | ₹20 Cr | ₹50 Cr | ₹57 Cr | ₹811,693 Cr |
What is the latest Consolidated Net Profit of NGL FINECHEM ?
Year | Consolidated Net Profit |
---|---|
Mar2025 | ₹41 Cr |
Mar2024 | ₹20 Cr |
Mar2023 | ₹50 Cr |
Mar2022 | ₹57 Cr |
Mar2021 | ₹811,693 Cr |
How is Consolidated Net Profit of NGL FINECHEM Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2025 | ₹41 Cr | 101.67 | |
Mar2024 | ₹20 Cr | -59.05 | |
Mar2023 | ₹50 Cr | -11.91 | |
Mar2022 | ₹57 Cr | -99.99 | |
Mar2021 | ₹811,693 Cr | - |
Compare Consolidated Net Profit of peers of NGL FINECHEM
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NGL FINECHEM | ₹884.6 Cr | 0% | 8.1% | -31.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹384,469.0 Cr | 0.5% | -2.3% | -12.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,672.0 Cr | 0.9% | -0.8% | 10.8% | Stock Analytics | |
CIPLA | ₹125,034.0 Cr | -0.3% | -0.9% | -3.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹119,542.0 Cr | -3% | -2.4% | 3.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,571.0 Cr | 0.6% | 3.9% | -0.4% | Stock Analytics |
NGL FINECHEM Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NGL FINECHEM | 0% |
8.1% |
-31.4% |
SENSEX | 1.2% |
1.9% |
-0.2% |
You may also like the below Video Courses